Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics (Q72371032)
scientific article published on 01 April 1994
Language:
Current Data About Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics
(P31) (Q13442814)
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

(P304) 302-308
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

(P407) (Q1860)

(P433) 4
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

(P478) 51
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

(P577) Friday, April 1, 1994
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

(P921) (Q269829)
(P887)

(Q409236)
(P887)

(Q178190)

(Q251347)
(P887)

(P1104) 7
(P887)

(P1433) (Q635830)
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

(P1476) "Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics" (language: en)
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

(P2093) C J McDougle
(P1545) 1
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

W K Goodman
(P1545) 2
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

J F Leckman
(P1545) 3
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

N C Lee
(P1545) 4
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

G R Heninger
(P1545) 5
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

L H Price
(P1545) 6
(P248)
(P698) 8161290
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8161290%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, October 26, 2019

other details
description scientific article published on 01 April 1994

External Links
(P356) 10.1001/ARCHPSYC.1994.03950040046006
(P698) 8161290